Provided by Tiger Trade Technology Pte. Ltd.

Curis

1.16
-0.0400-3.33%
Volume:83.19K
Turnover:99.08K
Market Cap:2.81M
PE:-0.08
High:1.24
Open:1.21
Low:1.16
Close:1.20
52wk High:39.00
52wk Low:1.16
Shares:2.43M
Float Shares:2.24M
Volume Ratio:1.38
T/O Rate:3.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-14.3309
EPS(LYR):-11.5193
ROE:-693.93%
ROA:-93.23%
PB:0.60
PE(LYR):-0.10

Loading ...

Analysts Are Bullish on These NA Stocks: Curis (CRIS), Canadian National Railway (CNI)

TIPRANKS
·
Aug 17

Curis Price Target Maintained with a $43.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 17

Curis Inc.’s 1-for-20 Reverse Split Raises Liquidity Concerns and Odd-Lot Trading Risks

TIPRANKS
·
Aug 16

Curis Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 15

Curis FY26 Q2 Net Loss Widens 71% to $32.78 Million vs FY25; Revenue Posts no Revenue vs FY25

Reuters
·
Aug 15

Curis Prices USD 5.6 Million Public Offering at USD 1.5 Per Share with Warrants

Reuters
·
Aug 13

Curis, Inc. Announces Pricing of $5.6 Million Public Offering

THOMSON REUTERS
·
Aug 13

Top News Today/Canada: Barrick Settles Newmont Dispute, Clearing Way to List Its Gold Assets

Dow Jones
·
Aug 11

Curis Inc Expected to Post a Loss of $7.84 a Share - Earnings Preview

Reuters
·
Aug 07

Curis Inc Expected to Post a Loss of $7.47 a Share - Earnings Preview

Reuters
·
Jul 31

Curis Regains NASDAQ Bid-price Compliance, Remains Under One-year Panel Monitor

Reuters
·
Jul 31

Curis Doses First Five Patients in TakeAim CLL Combo Trial of Emavusertib, Zanubrutinib

Reuters
·
Jul 30

Curis Doses First Five Patients in Takeaim Cll Study

THOMSON REUTERS
·
Jul 30

Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA), Bausch + Lomb Corporation (BLCO) and Curis (CRIS)

TIPRANKS
·
Jul 30

Curis is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jul 24

Curis, Inc. : H.c. Wainwright Raises Target Price to $43 from $17

THOMSON REUTERS
·
Jul 24

Curis Notifies Press Release Availability on Positive Emavusertib Update

Reuters
·
Jul 22

Curis Announces Positive Emavusertib Update

THOMSON REUTERS
·
Jul 22

Curis - to Dose Initial 5 Takeaim Cll Patients by End of July; Data Expected December 2026

THOMSON REUTERS
·
Jul 22

Curis consents first six patients in TakeAim CLL study

TIPRANKS
·
Jul 06